Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Gabay

Showing results (211-220 of 259) with videos related to

Pageof 26
Sort By:
The Journal of Allergy and Clinical Immunology|March 11, 2026
Pyrin Inflammasome Activation Triggers an IL-18-Driven IFNγ Response in Mevalonate Kinase DeficiencyNiels S van Heusden, Isa Cuijpers, Nils Meijer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2014
Myeloid-related proteins 8 and 14 contribute to monosodium urate monohydrate crystal-induced inflammation in goutDirk Holzinger, Nadine Nippe, Thomas Vogl, et al.
RMD Open|November 30, 2018
Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registriesKim Lauper, Denis Mongin, Florenzo Iannone, et al.
Dermatology (Basel, Switzerland)|January 10, 2015
The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologistsWolf-Henning Boehncke, Mark David Anliker, Curdin Conrad, et al.
Arthritis Research & Therapy|October 8, 2016
A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated diseaseEric Hatterer, Limin Shang, Pierre Simonet, et al.
Lancet (London, England)|July 27, 2020
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trialGerd R Burmester, Frank Buttgereit, Corrado Bernasconi, et al.
Rheumatology (Oxford, England)|September 2, 2017
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritisDeshiré Alpizar-Rodriguez, Rüdiger B Mueller, Burkhard Möller, et al.
Scientific Reports|October 18, 2023
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical careMyriam Riek, Almut Scherer, Burkhard Möller, et al.
Immunity|July 21, 2023
Targeted removal of macrophage-secreted interleukin-1 receptor antagonist protects against lethal Candida albicans sepsisHang Thi Thuy Gander-Bui, Joëlle Schläfli, Johanna Baumgartner, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 7, 2021
Excess Serum Interleukin-18 Distinguishes Patients With Pathogenic Mutations in PSTPIP1Deborah L Stone, Amanda Ombrello, Juan I Arostegui, et al.
Pageof 26

Showing results (211-220 of 259) with videos related to

Sort By:
Pageof 26
The Journal of Allergy and Clinical Immunology|March 11, 2026
Pyrin Inflammasome Activation Triggers an IL-18-Driven IFNγ Response in Mevalonate Kinase DeficiencyNiels S van Heusden, Isa Cuijpers, Nils Meijer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2014
Myeloid-related proteins 8 and 14 contribute to monosodium urate monohydrate crystal-induced inflammation in goutDirk Holzinger, Nadine Nippe, Thomas Vogl, et al.
RMD Open|November 30, 2018
Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registriesKim Lauper, Denis Mongin, Florenzo Iannone, et al.
Dermatology (Basel, Switzerland)|January 10, 2015
The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologistsWolf-Henning Boehncke, Mark David Anliker, Curdin Conrad, et al.
Arthritis Research & Therapy|October 8, 2016
A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated diseaseEric Hatterer, Limin Shang, Pierre Simonet, et al.
Lancet (London, England)|July 27, 2020
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trialGerd R Burmester, Frank Buttgereit, Corrado Bernasconi, et al.
Rheumatology (Oxford, England)|September 2, 2017
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritisDeshiré Alpizar-Rodriguez, Rüdiger B Mueller, Burkhard Möller, et al.
Scientific Reports|October 18, 2023
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical careMyriam Riek, Almut Scherer, Burkhard Möller, et al.
Immunity|July 21, 2023
Targeted removal of macrophage-secreted interleukin-1 receptor antagonist protects against lethal Candida albicans sepsisHang Thi Thuy Gander-Bui, Joëlle Schläfli, Johanna Baumgartner, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 7, 2021
Excess Serum Interleukin-18 Distinguishes Patients With Pathogenic Mutations in PSTPIP1Deborah L Stone, Amanda Ombrello, Juan I Arostegui, et al.
Pageof 26